NEJM Report: Next-Gen Gene Sequencing Solves Difficult Rare Infection Case
This article was originally published in The Gray Sheet
Clinicians used unbiased next-generation gene sequencing of cerebrospinal fluid in a boy with severe immunodeficiency to discover he was infected with a rare bacterial pathogen. The case, published in the New England Journal of Medicine, suggests next-generation sequencing may help doctors treat patients with diseases that cannot be identified through conventional testing, researchers say.
You may also be interested in...
Multiple firms are racing to develop an affordable whole-genome sequencing product as a marketable diagnostics tool, but clinicians and genetics experts told a government advisory panel last week that the practice is not yet ready for clinical application
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.